| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1251953-03-3 | 5-Bromo-2-pyridinemethanamine hydrochloride (1:2) | C6H7BrN2.2(HCl) |
| 1252003-15-8 | Tubastatin A;N-Hydroxy-4-((1,2,3,4-tetrahydro-2-methyl-5H-pyrido(4,3-b)indol-5-yl)methyl)benzamide | C20H21N3O2 |
| 1252018-10-2 | (R)-4-(4-((3-Chloro-2-hydroxypropyl)amino)phenyl)morpholin-3-one | C13H17ClN2O3 |
| 1252030-20-8 | 1-Benzyl-3-fluoro-1H-pyrrole | C11H10FN |
| 1252046-13-1 | 2-Bromo-5-iodobenzonitrile | C7H3BrIN |
| 1252555-61-5 | 4,4,9,9-Tetrakis(4-hexylphenyl)-2,7-bis(trimethylstannyl)-4,9-dihydro-s-indaceno(1,2-b:5,6-b)dithiophene;1,1'-(4,4,9,9-Tetrakis(4-hexylphenyl)-4,9-dihydro-s-indaceno(1,2-b:5,6-b')dithiophene-2,7-diyl)bis(1,1,1-trimethylstannane) | C70H90S2Sn2 |
| 1252576-14-9 | 2-((4S)-4,5-Dihydro-4-(phenylmethyl)-2-oxazolyl)quinoline | C19H16N2O |
| 1252594-99-2 | ETP 46321;5-(2-((4-(Methylsulfonyl)-1-piperazinyl)methyl)-8-(4-morpholinyl)imidazo(1,2-a)pyrazin-6-yl)-2-pyrimidinamine | C20H27N9O3S |
| 1252598-02-9 | Indazole-4-boronic acid, HCl | |
| 1252686-29-5 | tert-butyl (S)-(1-(4-ethoxyphenyl)-3-hydroxypropan-2-yl)carbamate;tert-butyl N-((2S)-1-(4-ethoxyphenyl)-3-hydroxypropan-2-yl)carbamate | C16H25NO4 |
| 1252761-56-0 | (4R)-4-(3,4-Dichlorophenyl)-2-pyrrolidinone | C10H9Cl2NO |
| 1252782-43-6 | 4-Fluoro-1H-indole-5-carboxylic acid methyl ester | C10H8FNO2 |
| 1252883-90-1 | N-Methyl-N-((3S,4S)-4-methyl-1-(phenylmethyl)-3-piperidinyl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine | C20H25N5 |
| 1252914-52-5 | N-Phenyl-4-dibenzothiophenamine | C18H13NS |
| 1252934-30-7 | 3-(Bromomethyl)-1,1-difluorocyclobutane | C5H7BrF2 |
| 1253055-87-6 | 6-Cyclopropylpyridine-3-boronic acid;B-(6-Cyclopropyl-3-pyridinyl)boronic acid | C8H10BNO2 |
| 1253055-92-3 | Methyl 3-amino-4-(2,4,5-trifluorophenyl)butanoate | C11H12F3NO2 |
| 1253056-01-7 | Sitagliptin Hydroxy Amide Impurity;3-hydroxy-1-(3-(trifluoromethyl)-5,6-dihydro-(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one | C16H14F6N4O2 |
| 1253056-18-6 | (2E)-1-(5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo(4,3-a)pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)-2-buten-1-one | C16H12F6N4O |
| 1253282-31-3 | Fmoc-Aph(Hor)-OH;(2S)-3-(4-(((4S)-2,6-dioxo-1,3-diazinane-4-carbonyl)amino)phenyl)-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid; 4-({((4S)-2,6-Dioxohexahydro-4-pyrimidinyl)carbonyl}amino)-N-((9H-fluoren-9-ylmethoxy)carbonyl)-L-phenylalanine | C29H26N4O7 |
| 1253291-12-1 | (4-(Difluoromethoxy)-3-(2-(2-pyridinyl)ethynyl)phenyl)(5,7-dihydro-6H-pyrrolo(3,4-b)pyridin-6-yl)methanone;GRN 529 | C22H15F2N3O2 |
| 1253452-78-6 | N-(4-(2-Hydroxyethyl)phenyl)-2-((4-nitrobenzoyl)amino)benzamide | C22H19N3O5 |
| 1253584-84-7 | 5-(2,4-Dihydroxy-6-(4-nitrophenoxy)phenyl)-N-(1-methyl-4-piperidinyl)-3-isoxazolecarboxamide;NMS-E 973 | C22H22N4O7 |
| 1253654-79-3 | 4,6-Dichloro-3-methylisoxazolo(5,4-d)pyrimidine | C6H3Cl2N3O |
| 1253654-82-8 | 8-Nitro-4-oxo-4H-1-benzopyran-3-carboxaldehyde | C10H5NO5 |
| 1253730-25-4 | 3-Oxetaneethanamine | C5H11NO |
| 1253789-67-1 | tert-Butyl (5-phenylpyrrolidin-3-yl)carbamate | C15H22N2O2 |
| 1253790-61-2 | 5-Amino-1-methyl-1H-pyrazole-3-carboxylic acid ethyl ester hydrochloride | C7H11N3O2.HCl |
| 1253792-57-2 | 5,6,7,8-Tetrahydro-1,7-naphthyridine-3-carboxylic acid methyl ester hydrochloride | C10H12N2O2.HCl |
| 1253792-86-7 | (4S)-rel-4-(((1,1-Dimethylethoxy)carbonyl)amino)-D-proline methyl ester | C11H20N2O4 |
| 1253799-29-9 | 3-(Bis(phenylmethyl)amino)-5-fluoro-6-methyl-2-(phenylmethoxy)benzoic acid phenyl ester | C35H30FNO3 |
| 1253888-80-0 | 5,6,7,8-Tetrahydro-1,7-naphthyridine-3-carboxylic acid methyl ester | C10H12N2O2 |
| 1253912-15-0 | (2,3-Dihydro-1H-indol-6-yl)boronic acid | C8H10BNO2 |
| 1253952-02-1 | 2,4-Dimethylbenzoic acid (4-((1S)-1-(aminomethyl)-2-(6-isoquinolinylamino)-2-oxoethyl)phenyl)methyl ester hydrochloride (1:2) | C28H27N3O3.2(HCl) |
| 1254036-66-2 | rel-N-(5-(4-(5-(((2R,6S)-2,6-Dimethyl-4-morpholinyl)methyl)-2-oxazolyl)-1H-indazol-6-yl)-2-methoxy-3-pyridinyl)methanesulfonamide | C24H28N6O5S |
| 1254036-77-5 | 6-(1H-Indol-4-yl)-4-(5-((4-(1-methylethyl)-1-piperazinyl)methyl)-2-oxazolyl)-1H-indazole hydrochloride (1:1) | C26H28N6O.HCl |
| 1254053-43-4 | Gilteritinib;6-Ethyl-3-((3-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)-2-pyrazinecarboxamide; ASP 2215 | C29H44N8O3 |
| 1254053-84-3 | Gilteritinib fumarate;ASP 2215 hemifumarate | 2(C29H44N8O3).C4H4O4 |
| 1254115-16-6 | 4-Fluoro-4-piperidinemethanol hydrochloride | C6H12FNO.HCl |
| 1254115-23-5 | 1-(3-Oxetanyl)piperazine | C7H14N2O |
| 1254205-52-1 | 4-(((3-Chloro-5-(trifluoromethyl)-2-pyridinyl)((4-(trifluoromethoxy)phenyl)methyl)amino)sulfonyl)benzoic acid | C21H13ClF6N2O5S |
| 1254251-27-8 | (2S)-2-Aminoundecanoic acid | C11H23NO2 |
| 1254276-84-0 | (Z)-(2-{(3R,4R,5R)-3,5-bis(tert-butyldimethylsilanyloxy)-2-methylene-4-(3-(tert-butyldiphenylsilanyloxy)propoxy)cyclohexylidene}ethyl)diphenylphosphine oxide;Eldecalcitol Intermediate | C52H75O5PSi3 |
| 1254319-51-1 | 6-bromo-2-methyl-2,3-dihydro-1H-isoindol-1-one | C9H8BrNO |
| 1254319-55-5 | 3-Bromo-6-methyl-5,6-dihydro-pyrrolo(3,4-b)pyridin-7-one | C8H7BrN2O |
| 1254353-37-1 | 5,6-Bis(octyloxy)-2,1,3-benzothiadiazole | C22H36N2O2S |
| 1254473-64-7 | 4-((1E)-2-(5-((1R)-1-(3,5-Dichloro-4-pyridinyl)ethoxy)-1H-indazol-3-yl)ethenyl)-1H-pyrazole-1-ethanol | C21H19Cl2N5O2 |
| 1254473-66-9 | 3,5-Dichloro-alpha-methyl-4-pyridinemethanol | C7H7Cl2NO |
| 1254576-93-6 | Diclofenac 2,5-Quinone Imine;5-Hydroxydiclofenac quinone imine | C14H9Cl2NO3 |
| 1254944-66-5 | SR 8278 | C18H19NO3S2 |